Dr. Leen Kawas Details Biotechnology Venture Capital Firms’ Recent Evolution

Dr. Leen Kawas, an experienced biotech innovator and entrepreneur, highlights industry changes propelling biotech venture capital firms. As 21st-century biotechnology advancements continue, they are fueling innovation in the healthcare, agricultural, marine, and industrial sectors, among others. Healthcare-related biotech discoveries receive the most visibility, as they often focus on new drug development and other therapies. Patients across the globe can potentially benefit from these treatments. Funding biotechnology innovations is typically an expensive proposition. A United States drug development cycle averages 12 years. This longer-term undertaking involves multi-stage clinical trials and regulatory...